Recent studies have demonstrated that PRDX6 could activate Akt through the activation of phosphoinositide 3-kinase (PI3K) and p38 kinase, and further induce uPA (urokinase plasminogen activator) to promote the invasion of lung cancer cells [21]. The gene discussed is AKT1; the disease is lung carcinoma.